Search Page

1

Cite

Share

Is there a Neurobiological Rationale for the Utility of the Iowa Gambling Task in Parkinson's Disease?

Salvatore MF, Soto I, Alphonso H, Cunningham R, James R, Nejtek VA. Salvatore MF, et al. J Parkinsons Dis. 2021;11(2):405-419. doi: 10.3233/JPD-202449. J Parkinsons Dis. 2021. PMID: 33361612 Free PMC article. Review.

Cite

Share

2

Cite

Share

Cardiovascular Metrics Associated With Prevention of Aging-Related Parkinsonian Signs Following Exercise Intervention in Sedentary Older Rats.

Kasanga EA, Little J, McInnis TR, Bugnariu N, Cunningham JT, Salvatore MF. Kasanga EA, et al. Among authors: salvatore mf. Front Aging Neurosci. 2021 Dec 15;13:775355. doi: 10.3389/fnagi.2021.775355. eCollection 2021. Front Aging Neurosci. 2021. PMID: 34975456 Free PMC article.

Cite

Share

3

Cite

Share

Tyrosine Hydroxylase Inhibition in Substantia Nigra Decreases Movement Frequency.

Salvatore MF, McInnis TR, Cantu MA, Apple DM, Pruett BS. Salvatore MF, et al. Mol Neurobiol. 2019 Apr;56(4):2728-2740. doi: 10.1007/s12035-018-1256-9. Epub 2018 Jul 28. Mol Neurobiol. 2019. PMID: 30056575 Free PMC article.

Cite

Share

4

Cite

Share

Premature cognitive decline in specific domains found in young veterans with mTBI coincide with elder normative scores and advanced-age subjects with early-stage Parkinson's disease.

Nejtek VA, James RN, Salvatore MF, Alphonso HM, Boehm GW. Nejtek VA, et al. Among authors: salvatore mf. PLoS One. 2021 Nov 17;16(11):e0258851. doi: 10.1371/journal.pone.0258851. eCollection 2021. PLoS One. 2021. PMID: 34788310 Free PMC article.

Cite

Share

5

Cite

Share

Aging-related limit of exercise efficacy on motor decline.

Arnold JC, Cantu MA, Kasanga EA, Nejtek VA, Papa EV, Bugnariu N, Salvatore MF. Arnold JC, et al. Among authors: salvatore mf. PLoS One. 2017 Nov 27;12(11):e0188538. doi: 10.1371/journal.pone.0188538. eCollection 2017. PLoS One. 2017. PMID: 29176896 Free PMC article.

Cite

Share

6

Cite

Share

Tyrosine hydroxylase as a sentinel for central and peripheral tissue responses in Parkinson's progression: Evidence from clinical studies and neurotoxin models.

Johnson ME, Salvatore MF, Maiolo SA, Bobrovskaya L. Johnson ME, et al. Among authors: salvatore mf. Prog Neurobiol. 2018 Jun-Aug;165-167:1-25. doi: 10.1016/j.pneurobio.2018.01.002. Epub 2018 Jan 10. Prog Neurobiol. 2018. PMID: 29331395 Review.

Cite

Share

7

Cite

Share

Ceftriaxone reduces L-dopa-induced dyskinesia severity in 6-hydroxydopamine parkinson's disease model.

Chotibut T, Meadows S, Kasanga EA, McInnis T, Cantu MA, Bishop C, Salvatore MF. Chotibut T, et al. Among authors: salvatore mf. Mov Disord. 2017 Nov;32(11):1547-1556. doi: 10.1002/mds.27077. Epub 2017 Jun 20. Mov Disord. 2017. PMID: 28631864 Free PMC article.

Cite

Share

8

Cite

Share

Peripheral and cognitive signs: delineating the significance of impaired catecholamine metabolism in Parkinson's disease progression.

Salvatore MF, Disbrow EA, Emborg ME. Salvatore MF, et al. J Neurochem. 2014 Oct;131(2):129-33. doi: 10.1111/jnc.12796. Epub 2014 Jul 5. J Neurochem. 2014. PMID: 25039428 Free article. No abstract available.

Cite

Share

9

Cite

Share

Prolonged increase in ser31 tyrosine hydroxylase phosphorylation in substantia nigra following cessation of chronic methamphetamine.

Salvatore MF, Nejtek VA, Khoshbouei H. Salvatore MF, et al. Neurotoxicology. 2018 Jul;67:121-128. doi: 10.1016/j.neuro.2018.05.003. Epub 2018 May 18. Neurotoxicology. 2018. PMID: 29782882 Free PMC article.

Cite

Share

10

Cite

Share

Constitutive Ret signaling leads to long-lasting expression of amphetamine-induced place conditioning via elevation of mesolimbic dopamine.

Kopra J, Villarta-Aguilera M, Savolainen M, Weingerl S, Myöhänen TT, Rannanpää S, Salvatore MF, Andressoo JO, Piepponen TP. Kopra J, et al. Among authors: salvatore mf. Neuropharmacology. 2018 Jan;128:221-230. doi: 10.1016/j.neuropharm.2017.10.010. Epub 2017 Oct 13. Neuropharmacology. 2018. PMID: 29031851 Free PMC article.

Cite

Share